Indeed, on the one hand, tumor-derived EVs carry FasL and TRAIL molecules and can directly induce apoptosis of DCs (Peng et al., 2011; Ning et al., 2018) or effector CD4+ and CD8+ T-lymphocytes (Whiteside, 2016a). The gene discussed is CD8A; the disease is neoplasm.